Certification is possible provided that
Acceptable DOACs are Dabigatran, Rivaroxaban and Apixaban.
Likely indications include:
Prior to certification, for pilots taking warfarin the INR should be demonstrated to be within the target range for 6 months (4 results at 2 monthly intervals) and 2 monthly laboratory testing should be continued on an ongoing basis. If the INR varies considerably within the target range on the initial readings, a longer period of surveillance may be required. Pilots taking DOACs should be free of side effects for a period of 3 months prior to fitness reassessment.
Class 1 applicants treated with warfarin are required to measure their INR on a ‘near patient’ testing system (such as CoaguChek S) 12 hours prior to flight and only fly if the INR is within the target range. The INR should be recorded in the Log Book. The Log Book should be reviewed at each medical certificate revalidation examination.
For LAPL pilots, a shorter period of stabilisation (6 weeks for DOACs and 4 months for warfarin) may be acceptable provided there are no side effects and there is reliable evidence of INR stability in pilots taking warfarin.
If you are jetting off this bank holiday weekend take a quick look at our top tips https://t.co/a5vGh8hXlW to help… https://t.co/mZ4SiBBqWW
21 hours ago
If you are planning on hiring a commercial drone operator, make sure they are fully approved… https://t.co/Tri848CSP2
The UK Civil Aviation Authority confirms that Richard Moriarty today (24 May 2018) becomes its new Chief Executive… https://t.co/1FpfIwWMwj
2 days ago
Read all @UK_CAA
CAA begins new round of funding for 8.33 kHz radio switchover
25 May, 2018
Only use approved commercial drone users or you could be out of pocket – warns CAA
24 May, 2018
Confirmation of Chief Executive appointment
24 May, 2018
Read all News
Sharing the cost of recreational flying
4 May, 2018
Planning your next holiday abroad?
10 April, 2018
‘Share the Air’ gets off to a flying start
1 December, 2017
Read All Blogs